<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>RLAXE reading room</title><link>https://rlaxe.local/read/</link><description>Evidence-led research briefs.</description><item><title>What can a batch COA tell you?</title><link>https://rlaxe.local/read/batch-coa/</link><description>How to read identity, date, analytes, potency and test scope without turning one record into a universal promise.</description><pubDate>2026-09-10</pubDate></item><item><title>What is the difference between a product attribute and a health claim?</title><link>https://rlaxe.local/read/attribute-vs-health-claim/</link><description>A plain-language classification tool for separating observable product details from efficacy, medical and testimonial wording.</description><pubDate>2026-09-10</pubDate></item><item><title>How do you read a wellness label without filling gaps?</title><link>https://rlaxe.local/read/wellness-label/</link><description>Use the label as a bounded record: ingredients, serving, warnings, manufacturer, lot and language, with absent fields kept visible.</description><pubDate>2026-09-10</pubDate></item><item><title>What does “third-party tested” actually tell you?</title><link>https://rlaxe.local/read/third-party-tested/</link><description>Testing language becomes useful only when the lab, method, batch match and test date can be traced.</description><pubDate>2026-09-10</pubDate></item><item><title>What is a calm checklist for comparing two product pages?</title><link>https://rlaxe.local/read/compare-product-pages/</link><description>Compare stable fields, preserve “not found”, and keep source dates and commercial disclosures beside the decision.</description><pubDate>2026-09-10</pubDate></item><item><title>Why can one product page not answer a worldwide legality question?</title><link>https://rlaxe.local/read/worldwide-legality/</link><description>Country, state or province, intended use, channel and claim wording all change the question.</description><pubDate>2026-09-10</pubDate></item><item><title>What does a US evidence map show—and what does it not show?</title><link>https://rlaxe.local/read/us-evidence-map/</link><description>A federal source is not a state shipping plan. Keep destination, claims, processor and channel questions separate.</description><pubDate>2026-09-10</pubDate></item><item><title>How should a Canada evidence map handle regulated channels?</title><link>https://rlaxe.local/read/canada-evidence-map/</link><description>Separate licensed routes, provincial context and cross-border assumptions; record access dates and open questions.</description><pubDate>2026-09-10</pubDate></item><item><title>Why do similar words hide different routes across six markets?</title><link>https://rlaxe.local/read/six-market-routes/</link><description>GB, Ireland/EU, Australia and New Zealand can share vocabulary while differing in classification and route questions.</description><pubDate>2026-09-10</pubDate></item><item><title>How do you build a jurisdiction × SKU × claim register?</title><link>https://rlaxe.local/read/jurisdiction-sku-claim-register/</link><description>A blank field model turns a broad research question into owners, excerpts, freshness dates and next checks.</description><pubDate>2026-09-10</pubDate></item><item><title>Why is shipping a product decision?</title><link>https://rlaxe.local/read/shipping-product-decision/</link><description>Destination eligibility, carrier rules, returns, recalls, tax and importer route belong in the evidence record.</description><pubDate>2026-09-10</pubDate></item><item><title>Why is payment-platform availability not product approval?</title><link>https://rlaxe.local/read/payment-platform/</link><description>Platform support, processor terms and product or jurisdiction acceptance are separate dispositions.</description><pubDate>2026-09-10</pubDate></item><item><title>What evidence should a careful buyer see before checkout?</title><link>https://rlaxe.local/read/pre-checkout-evidence/</link><description>Product facts, source date, disclosure, returns and a contact route are more useful than urgency or a star rating.</description><pubDate>2026-09-10</pubDate></item><item><title>How can you document a supplier without copying supplier marketing?</title><link>https://rlaxe.local/read/supplier-documentation/</link><description>Keep supplier wording, independent confirmation, open questions and stale-source actions distinct.</description><pubDate>2026-09-10</pubDate></item><item><title>What is inside a redacted internal dossier?</title><link>https://rlaxe.local/read/redacted-dossier/</link><description>A synthetic record shows how SKU, claim, source, channel and unknown fields fit together without implying certification.</description><pubDate>2026-09-10</pubDate></item><item><title>What does original comparison content look like?</title><link>https://rlaxe.local/read/original-comparison/</link><description>Method, testing, synthesis and navigation distinguish useful editorial work from copied descriptions or thin affiliation.</description><pubDate>2026-09-10</pubDate></item><item><title>How can a commercial relationship be disclosed without breaking trust?</title><link>https://rlaxe.local/read/commercial-disclosure/</link><description>Put plain-language disclosure next to the first referral action and keep it separate from editorial judgment.</description><pubDate>2026-09-10</pubDate></item><item><title>Why is a correction log part of the product?</title><link>https://rlaxe.local/read/correction-log/</link><description>A visible record of changed source, impact, owner, date and replacement makes uncertainty actionable.</description><pubDate>2026-09-10</pubDate></item><item><title>What should be rechecked monthly, quarterly or on trigger?</title><link>https://rlaxe.local/read/freshness-budgets/</link><description>Set risk-based freshness budgets for policy, payment, product, shipping and competitor records.</description><pubDate>2026-09-10</pubDate></item><item><title>What can RLAXE tell you today—and what can it not?</title><link>https://rlaxe.local/read/rlaxe-today/</link><description>RLAXE is an evidence utility with explicit limits, not a doctor, regulator, certifier, retailer or worldwide authority.</description><pubDate>2026-09-10</pubDate></item></channel></rss>